UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurokinin A (NK 2) receptor revisited with SR 48968, a potent non-peptide antagonist

Biochemical and biophysical research communications, 1992-05, Vol.184 (3), p.1418-1424

1992

Volltextzugriff (PDF)

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Life sciences (1973), 1995, Vol.56 (23), p.1941-1947

1995

Volltextzugriff (PDF)

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1992-08, Vol.262 (2), p.759

1992

Volltextzugriff (PDF)

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

The Journal of pharmacology and experimental therapeutics, 1998-02, Vol.284 (2), p.644

1998

Volltextzugriff (PDF)

Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A

Neuropharmacology, 1993-06, Vol.32 (6), p.605-615

1993

Volltextzugriff (PDF)

Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors

Neuropharmacology, 1994-02, Vol.33 (2), p.167-179

1994

Volltextzugriff (PDF)

Characterization of the Binding Sites of [3H]SR 48968, a Potent Nonpeptide Radioligand Antagonist of the Neurokinin-2 Receptor

Biochemical and biophysical research communications, 1993-03, Vol.191 (3), p.1172-1177

1993

Volltextzugriff (PDF)

Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor

Molecular pharmacology, 1994-03, Vol.45 (3), p.500-508

1994

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist

Neuropeptides (Edinburgh), 1997-10, Vol.31 (5), p.449-458

1997

Volltextzugriff (PDF)

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain

Molecular pharmacology, 1993-01, Vol.43 (1), p.84-89

1993

Volltextzugriff (PDF)

Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

Psychopharmacologia, 1999-05, Vol.144 (2), p.144-150

1999

Volltextzugriff (PDF)

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1993-05, Vol.265 (2), p.826

1993

Volltextzugriff (PDF)

Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate

Annals of the rheumatic diseases, 1986-01, Vol.45 (1), p.67-74

1986

Volltextzugriff (PDF)

Development of tetrazole bioisosteres in angiotensin II antagonists

Bioorganic & medicinal chemistry letters, 1994-01, Vol.4 (1), p.45-50

1994

Volltextzugriff (PDF)

Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747

Journal of neuroimmunology, 1994-07, Vol.52 (2), p.183-192

1994

Volltextzugriff (PDF)

Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists

FEBS letters, 1996-12, Vol.399 (3), p.321-325

1996

Volltextzugriff (PDF)

Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors

Proceedings of the National Academy of Sciences - PNAS, 1993-07, Vol.90 (13), p.6194-6198

1993

Volltextzugriff (PDF)

Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat

Fundamental & clinical pharmacology, 1998-01, Vol.12 (1), p.88-94

1998

Volltextzugriff (PDF)

Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors

The American review of respiratory disease, 1992-11, Vol.146 (5 Pt 1), p.1177-1181

1992

Volltextzugriff (PDF)

Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses

Journal of neuroimmunology, 1994-07, Vol.52 (2), p.193-203

1994

Volltextzugriff (PDF)

A potent and selective non-peptide antagonist of the neurokinin a (NK 2) receptor

Life sciences (1973), 1992, Vol.50 (15), p.PL101-PL106

1992

Volltextzugriff (PDF)

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

European journal of pharmacology, 1993-12, Vol.250 (3), p.403-413

1993

Volltextzugriff (PDF)

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

FEBS letters, 1994-08, Vol.350 (2), p.240-244

1994

Volltextzugriff (PDF)

Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: tonic and phasic muscular activities

Canadian journal of physiology and pharmacology, 1997-06, Vol.75 (6), p.587-590

1997

Volltextzugriff (PDF)

Characterization and distribution of binding sites for [ 3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

Life sciences (1973), 1996, Vol.58 (15), p.1239-1247

1996

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(97)
Dissertationen
(1)

Sprache

Englisch
(88)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurokinin A (NK 2) receptor revisited with SR 48968, a potent non-peptide antagonist

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A

Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors

Characterization of the Binding Sites of [3H]SR 48968, a Potent Nonpeptide Radioligand Antagonist of the Neurokinin-2 Receptor

Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor

Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain

Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist

Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate

Development of tetrazole bioisosteres in angiotensin II antagonists

Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747

Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists

Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors

Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat

Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors

Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses

A potent and selective non-peptide antagonist of the neurokinin a (NK 2) receptor

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: tonic and phasic muscular activities

Characterization and distribution of binding sites for [ 3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

Suchergebnisse filtern